Taro Pharmaceutical USA Inc

General

Total Cases21

Active Cases1

Patents--

CourtsD. New Jersey S.D. New York D. Delaware

TypeOperating Company

Elite Ratings

--

taro-pharmaceuticals

taro-pharmaceuticals

Ratings

Experience

Grade

Trend

DCT

L5

E

PTAB

L4

A

CAFC

L4

C

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
09/06/24	Bayer Pharma AG v. Lupin Ltd 1:21-CV-00314 ( D. DE )	Joint Status Report Regarding Stay, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Bayer Intellectual Property GMBH. (Fahnestock, Derek) Modified on 9/6/2024 (nms). (Entered: 09/06/2024)
04/09/24	Bayer Pharma AG v. Lupin Ltd 1:21-CV-00314 ( D. DE )	Answer to Complaint and Counterclaims (D.I. 10 in 24-cv-138-RGA; D.I. 10 in 24-cv-138-RGA), by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 4/10/2024 (nms). (Entered: 04/09/2024)
04/02/24	Bayer Pharma AG v. Lupin Ltd 1:21-CV-00314 ( D. DE )	SO ORDERED Granting (D.I. 162 in 21-cv-314-RGA-LDH; D.I. 13 in 24-cv-138-RGA; D.I. 255 in 21-md-3017-RGA-LDH) Stipulation and Order Regarding Consolidation and Schedule. Signed by Judge Richard G. Andrews on 4/2/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:21-cv-00314-RGA-LDH, 1:24-cv-00138-RGA(nms) (Entered: 04/02/2024)
04/01/24	Bayer Pharma AG v. Lupin Ltd 1:21-CV-00314 ( D. DE )	STIPULATION and Order Regarding Consolidation and Schedule - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 04/01/2024)
03/08/24	Bayer Pharma AG v. Lupin Ltd 1:21-CV-00314 ( D. DE )	Joint Status Report Regarding Stay, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 3/11/2024 (nms). (Entered: 03/08/2024)
12/22/23	Bayer Pharma AG v. Lupin Ltd 1:21-CV-00314 ( D. DE )	NOTICE requesting Clerk to remove Elham Firouzi Steiner as co-counsel. Reason for request: No longer with the firm of Wilson Sonsini Goodrich & Rosati. (Moore, David) (Entered: 12/22/2023)
12/15/23	Bayer Pharma AG v. Lupin Ltd 1:21-CV-00314 ( D. DE )	SO ORDERED Granting (D.I.158 in 21-cv-314-RGA-LDH; D.I. 14 in 23-cv-1196-RGA; D.I. 202 in 21-md-3017-RGA-LDH) Stipulation and Order Regarding Consolidation and Schedule: Civil Action 23-1196-RGA is consolidated with Civil Action 21 314-RGA-JLH for all purposes, including for trial. All papers shall be filed in Civil Action 21-314-RGA-JLH (see Order for further details). Signed by Judge Richard G. Andrews on 12/15/2023. Associated Cases: 1:21-md-03017-RGA-LDH, 1:21-cv-00314-RGA-LDH, 1:23-cv-01196-RGA(nms) (Entered: 12/15/2023) SO ORDERED Granting (D.I.158 in 21-cv-314-RGA-LDH; D.I. 14 in 23-cv-1196-RGA; D.I. 202 in 21-md-3017-RGA-LDH) Stipulation and Order Regarding Consolidation and Schedule: Civil Action 23-1196-RGA is consolidated with Civil Action 21 314-RGA-JLH for all purposes, including for trial. All papers shall be filed in Civil Action 21-314-RGA-JLH (see Order for further details). Signed by Judge Richard G. Andrews on 12/15/2023. Associated Cases: 1:21-md-03017-RGA-LDH, 1:21-cv-00314-RGA-LDH, 1:23-cv-01196-RGA(nms) (Entered: 12/15/2023)
12/15/23	Bayer Pharma AG v. Lupin Ltd 1:21-CV-00314 ( D. DE )	STIPULATION and [Proposed] Order Regarding Consolidation and Schedule, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 12/15/2023 (nms). (Entered: 12/15/2023)
10/06/23	Bayer Pharma AG v. Lupin Ltd 1:21-CV-00314 ( D. DE )	NOTICE requesting Clerk to remove Ty W. Callahan as co-counsel. Reason for request: No longer with the firm of Wilson Sonsini Goodrich & Rosati. (Palapura, Bindu) (Entered: 10/06/2023)
10/04/23	Bayer Pharma AG v. Lupin Ltd 1:21-CV-00314 ( D. DE )	Case no longer referred to Judge Jennifer L. Hall for discovery. (nms) (Entered: 10/04/2023)